|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA.
|
20122609 |
2010 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
The patients with myocardial infarction after administration of alteplase had statistically significantly higher coronary flow (TIMI-3), 72.5% as compared to the patients who received streptokinase, 39.2%.
|
19341228 |
2009 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Key role of tissue plasminogen activator in neurovascular coupling.
|
18195371 |
2008 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
|
15215796 |
2004 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Cocaine-induced coronary thrombosis and acute myocardial infarction.
|
15301905 |
2004 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Angioplasty in acute myocardial infarction after low-dose alteplase and abciximab in transferred patients. A comparison with primary angioplasty on site.
|
12848087 |
2003 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Spinal epidural hematoma following tissue plasminogen activator and heparinization for acute myocardial infarction.
|
12227717 |
2002 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Lanoteplase plasma clearance averaged 3 L/h (50 ml/min), whereas the mean plasma clearance of approximately 24 L/h (400 ml/min) for alteplase approaches hepatic blood flow following acute myocardial infarction.
|
12074692 |
2002 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
New heparin dosing recommendations for patients with acute coronary syndromes.
|
11382373 |
2001 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).
|
11489769 |
2001 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
|
10914357 |
2000 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Spontaneous compartment syndrome after thrombolytic therapy.
|
10645301 |
1999 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Cocaine induced myocardial infarction.
|
10505926 |
1999 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
|
9183334 |
1997 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
|
8554022 |
1996 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
|
8598594 |
1996 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Current issues concerning thrombolytic therapy for acute myocardial infarction.
|
7775709 |
1995 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Thrombolytic treatment and proteinuria.
|
7488445 |
1995 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy.
|
7902905 |
1994 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
[New substances and dosages for thrombolysis in acute myocardial infarct].
|
8328192 |
1993 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
|
10171637 |
1993 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Severe acute myocardial infarction during a staphylococcal septicemia with meningoencephalitis. A possible contraindication to thrombolytic treatment.
|
1430592 |
1992 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
The frequency and severity of adverse effects resulting from the administration of streptokinase and alteplase were determined in 126 consecutive patients who received standard dosages of these agents for the treatment of acute myocardial infarction.
|
1492007 |
1992 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
|
1899364 |
1991 |
|
Myocardial Infarction
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication.
|
1898952 |
1991 |